Literature DB >> 18625160

ONTARGET for hypertension or not?

Thomas Giles.   

Abstract

Entities:  

Year:  2008        PMID： 18625160     DOI： 10.1007/s11906-008-0056-4

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  5 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  The new European Society of Hypertension/European Society of Cardiology (ESH/ESC) Guidelines.

Authors:  Giuseppe Mancia; Guido Grassi
Journal:  Ther Adv Cardiovasc Dis       Date:  2008-02

3.  Nifedipine-associated myocardial ischemia or infarction in the treatment of hypertensive urgencies.

Authors:  J J O'Mailia; G E Sander; T D Giles
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

4.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

5.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Authors:  Marc A Pfeffer; John J V McMurray; Eric J Velazquez; Jean-Lucien Rouleau; Lars Køber; Aldo P Maggioni; Scott D Solomon; Karl Swedberg; Frans Van de Werf; Harvey White; Jeffrey D Leimberger; Marc Henis; Susan Edwards; Steven Zelenkofske; Mary Ann Sellers; Robert M Califf
Journal:  N Engl J Med       Date:  2003-11-10       Impact factor: 91.245
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.